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Coumarins are natural polyphenol lactones comprising of fused rings of benzene and
α-pyrone. The current study demonstrates the inhibitory effect of coumarins with various
substitutions on Mycobacterium smegmatis mc2 155. We also demonstrate the effect
of pomegranate (Punica granatum) extract containing ellagic acid, on M. smegmatis as
well as their affect on MtbFtsZ (FtsZ from Mycobacterium tuberculosis). The ellagic acid
extracts from pomegranate peels inhibit mycobacteria with a MIC of 25 µM and 0.3 to
3.5mg/mL, respectively, but failed to inhibit the polymerization of MtbFtsZ. However,
the coumarins were shown to inhibit the polymerization and GTPase activity of the
protein as well as have an inhibitory affect on M. smegmatis mc2 155. Docking of
the most active coumarin (7-Dimethyl-4-methyl coumarin with MIC of 38.7 µM) to the
GTP binding site suggests that it interacted with the G103 residue. Based on the
docking results two mutants of varying activity (G103S and G103A) were constructed
to elucidate the interaction of MtbFtsZ and coumarins. Mutation of G103 with Serine
(a bulky group) results in an inactive mutant and substitution with alanine produces a
variant that retains most of the activity of the wild type. There is a disruption of the
protofilament formation of the MtbFtsZ upon interaction with coumarins as demonstrated
by TEM. The coumarins increase the length of Mycobacteria five times and MtbFtsZ
localization is disturbed. The mutant proteins altered the GTPase and polymerization
activity of coumarins as compared to wild type protein. The results here support that
coumarins inhibit proliferation of Mycobacteria by targeting the assembly of MtbFtsZ
and provide the possible binding site of coumarins on MtbFtsZ. This study may aid in
the design of natural products as anti-mycobacterial agents. The currently reported GTP
analogs for FtsZ are toxic to the human cell lines; natural coumarins targeting the GTP
binding site of MtbFtsZ may hold promise as an important drug lead for tuberculosis
treatment.
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INTRODUCTION
Tuberculosis is the second leading infectious disease with highest mortality in the world, caused by
Mycobacterium tuberculosis (Zumla, 2015). The emergence of X/MDR strains (Extensively/multi
drug-resistant TB) has complicated the scenario thereby necessitating several groups to focus
on newer targets, synthesis of novel compounds and explore natural products that can
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serve as leads for the design of anti-tubercular drugs (Palomino
et al., 2009; Lima et al., 2015; Zumla, 2015). Among the targets,
Filamentous temperature-sensitive mutant Z (FtsZ) protein is
an essential bacterial protein which comprises of nucleotide
binding N and C-terminal domains with the (tubulin)-like
synergy loop (T7 loop). FtsZ is involved in Z-ring formation,
which is formed after the segregation of nuclear material during
the membrane constriction (Egan et al., 2013). The amino
acid motif, GGGTGTG is similar to the signature sequence of
tubulin—thus termed as bacterial tubulin homolog (Egan et al.,
2013; Hong and Xie, 2013). Its nucleotide binding region is
involved in assembly of the individual monomers to form a
protofilament. FtsZ is a self-activating GTPase and the catalytic
site is formed by the interaction of two monomers in a head
to tail manner, where in the GTP binding domain interacts
with the T7 loop of the adjacent monomer (Bernander and
Ettema, 2010). The protofilament thus formed will interact to
form bundle, pairs, sheets that is the integral part of the “Z”-ring
(Chan et al., 2014). Inhibition of FtsZ leads to cell elongation
and eventually death of the organism thus motivating many
research groups to focus on the design of inhibitors targeting
this enzyme (Leung et al., 2000, 2004; Jaiswal et al., 2007; Chan
et al., 2015). Cinnamaldehyde, berberine, curcumin, viriditoxin,
and chrysophaentins A-H, are reported to be potent inhibitors
against a wide range of bacteria and they target the GTPase and
the polymerization ability of FtsZ (Artola et al., 2015; Li and
Ma, 2015). Structure based virtual screening of small molecule
libraries identified 3-alkoxylbenzamide derivatives as potent
inhibitors of MRSA strains of Staphylococcus, and PC190723
is the most promising compound inhibiting the FtsZ GTPase
activity (Anderson et al., 2012; Stokes et al., 2013; Singh et al.,
2014). Drug discovery studies that focussed on scaffolds such as
naphthalenes, benzimidazoles, and pyrimidopyrazines targeting
FtsZ were reasonably successful (Jaiswal et al., 2007). Quinoloines
and taxanes were reported to specifically inhibit MtbFtsZ (Sun
et al., 2014). Screening of known tubulin inhibitors against
M. tuberculosis identified derivatives of pyridopyrazine and
pteridine. They inhibit Mycobacteria by targeting the MtbFtsZ
protein (Mathew et al., 2011). Recently we reported the role
of dihydroquinolines in inhibiting Mycobacteria by targeting
MtbFtsZ (Duggirala et al., 2016).
Coumarins are a set of natural compounds found in different
plants with as many as 1300 of them being identified as
secondary metabolites (Keri et al., 2015). Chemically they
are synthesized by Wittig’s and Reformatorsky’s reactions (Lv
et al., 2014). Coumarins find varied applications as additives
in foods, perfumes, cosmetics, dyes and pharmaceuticals. The
unique versatile scaffold of coumarin backbone is prone to
modifications and derivatization with several functional groups,
thereby leading to construction of structure based libraries
(Min et al., 2012). They can bind to many ligands and
are categorized as “privileged structures” thus affecting many
biological functions such as inflammatory process, redox balance,
blood coagulation, apoptosis etc (Peng et al., 2013; Vazquez-
Rodriguez et al., 2015). Their pharmacological properties are
attributed to the 2H-chromen-2-one nucleus composed of the
lactone and aromatic ring. The two oxygen atoms in the
lactone ring interact with the important amino acid residues of
enzymes thereby impacting the biological processes. Drugs in
the market possessing the coumarin scaffold are anticoagulants
namely acenocoumarol, dicoumarol, warfarin and antibiotic such
as novobiocin (Gellert et al., 1976). The aromatic ring forms
hydrophobic interaction with the carbon residues of the protein
to destabilize the enzyme (Musa et al., 2008; Riveiro et al., 2010).
Coumarins with long chain hydrocarbon substitution such as
ostruthin, ammoresinol, anthogenol, novobiocin, coumermycin,
and chartreusin demonstrate anti-bacterial activity on many
gram positive and gram negative bacteria (Matos et al., 2012;
Garro et al., 2014). Although none of the commercially
available anti-TB drugs possess coumarin scaffold, scopoletin
and umbelliferone are active againstMycobacterium tuberculosis
H37Rv, with MIC values of 42 and 58.3 µg/mL, respectively
(Rezayan et al., 2012; Upadhyay et al., 2012). The biological
activity of coumarins and their target depends on substitution
patterns of the functional groups (Venugopala et al., 2013).
Target based drug therapy is well explored in drug discovery
programs, hence the characterization of coumarins as potent
anti-mycobacterial agents and elucidating their target, would add
strength to the search for novel drugs.
Pomogranate was known for its anti-bacterial, anti-viral, anti-
cancer, anti-inflammatory, anti-oxidant properties. Pomegranate
peel is a rich source of tannins, flavonoids and polyphenols
(Ambigaipalan et al., 2016). Ethanolic extract and methanol
extract of pomegranate husk are a good source of ellagic acid
(Nankar and Doble, 2015). The ethanol extracts from the peels
possess anti-bacterial activity against the salmonella strains
(Wafa et al., 2017). In lieu of the anti-bacterial properties of
the pomegranate peels, here we use the ethanol and methanol
extracts to analyse their anti-mycobacterial property. Earlier
we reported the anti-bacterial effect of natural coumarins and
identified their role in targeting the FtsZ from E. coli (Duggirala
et al., 2014). Here we screened these compounds and pure ellagic
acid from pomegranate extracts (Punica granatum) for their
inhibitory effect on Mycobacteria and MtbFtsZ. The coumarins
inhibited the activity of MtbFtsZ and the mutations altered their
sensitivity further. Based on studies on the mutant enzymes we
propose that the binding site of coumarins at MtbFtsZ could be
G103 residue.
MATERIALS AND METHODS
GTP and IPTG were purchased from Sigma, St. Louis,
USA. Middlebrook 7H9 Broth and 7H10 agar media base
were purchased from BD, Biosciences USA. Coumarins were
purchased from TCI chemicals, Japan. DMSO was purchased
from Merck, USA. All other chemicals are of analytical grade.
Different coumarins with substitutions at the 7th position were
chosen as indicated previously (Duggirala et al., 2014).
Expression and Purification of MtbFtsZ
pSAR 1 plasmid harboring MtbFtsZ gene in pET15 vector is
a kind gift from Dr. Malini Rajagoplan, University of Texas,
USA. Protein was expressed in E. coli BL21 (DE3) Rosetta cells.
MtbFtsZ is a soluble protein and it was expressed by induction of
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IPTG, and purified by Ni-NTA column chromatography (Chen
et al., 2007; Duggirala et al., 2016). The protein was analyzed on
SDS-PAGE and its purity was determined to be >95%. The gel
was visualized in BioRad gel dock system and Quantity one 4.6.9
software. Protein concentration was measured by BCA method
and stored at −80◦C until further use The protein was stable in
25 mM HEPES buffer (pH 6.5), 50mM KCl and 5 mM MgCl2.
(Rajagopalan et al., 2005).
Preparation of Pomegranate Peels Extract
Peels of kesar pomegranate fruit were obtained from Andavar
fruit shop, IIT Madras Campus, Chennai, India. Methanol
extract (MethExt) and ethyl acetate fraction of methanol extract
(EthAcFr) were prepared from pomegranate peels as mentioned
previously (Nankar and Doble, 2015). MethExt and EthAcFr
contain 2% w/w and 17% w/w of ellagic acid, respectively. The
extracts were lyophilized and the powder was suspended in
DMSO. These two extracts and pure ellagic acid were screened
for their ability to inhibit Mycobacteria.
Docking of Coumarins
The crystal structure of MtbFtsZ (PDB ID- 2Q1Y) was chosen as
the target for docking of coumarins. The protein was downloaded
and prepared for docking by removing the water molecules
and subsequently minimizing its energy in Molecular operating
environment (MOE), 2014.08; Chemical Computing Group,
Canada). The structures of coumarins were sketched in Chem
Draw (Chem Draw, Chambridge, Soft, USA) and the energy was
minimized using MMF94X force field available in MOE. The
GTP binding site was defined by forming a cavity around it and
the bound GTP was removed and the coumarins were docked at
this site. For docking in the T7 loop a 10 A◦ radius was chosen
around the major T7 loop residue. Docking was performed using
the program Genetic Optimization for Ligand Docking (GOLD),
suite 5.2 (CCDC, UK) (Gupta et al., 2011). The best GOLD scores
for each of the inhibitors were reported here.
Site Directed Mutagenesis of G103
Residue of MtbFtsz
Quick change site directed mutagenesis kit (Agilent,
technologies) was used to mutate the MtbFtsZ gene at G103
position. pSAR1 plasmid was used as the template to induce
mutation at the G103 site to generate G103S and G103Amutants.
The primers for the mutations are listed in Table 1.
The PCR products were subjected to dpn1 digestion and
the resultant products were transformed in E. coli DH5α cells.
The plasmid was isolated from the resultant colonies and the
mutation was confirmed by full-length plasmid sequencing
(Eurofins, India). The protein was expressed in the same host as
wild type, purified and concentrated as per the protocol used for
the wild type (Chen et al., 2007).
Effect of Coumarins on the Polymerization
Activity of MtbFtsZ
The ability of the coumarins to inhibit the polymerization and
GTPase activity of MtbFtsZ was measured (both wild type and
mutant proteins). 6 µM of MtbFtsZ, was polymerized in 25 mM
TABLE 1 | Primers used in the study.
Construct Primers
G103S FP - GTCACCGCCGGCGAG AGC GGCGGAACCGGCACC
RP - GGTGCCGGTTCCGCC GCT CTCGCCGGCGGTGAC
G103A FP - GTCACCGCCGGCGAG GCG GGCGGAACCGGCACC
RP - GGTGCCGGTTCCGCC CGC CTCGCCGGCGGTGAC
HEPES buffer, pH 6.5, 50 mM KCl and 5 mM MgCl2 on ice,
in the presence and absence of compounds. The polymerization
reaction was monitored in a fluorescence spectrophotometer
(JASCO 6500) with both the excitation and emission wavelengths
set at 400 nm, and temperature set at 30◦C. At the end of 300 s 1
mM of GTP was added and the light scattering was recorded till
1,000 s (Jaiswal et al., 2007).
Effect of Coumarins on the GTPase Activity
of MtbFtsZ
6 µM of MtbFtsZ (wild type and mutant proteins) was incubated
in MOPS buffer (50mM MOPS pH 7.2, 5mM MgCl2, 200mM
KCl) in the presence and absence of coumarins. GTP was added
and the reaction was incubated at 37◦C for 15min. BIOMOL
Malachite green reagent (BIOMOL R© Green reagent, Enzo Life
Sciences, USA) was used to measure the free inorganic phosphate
released (Matsui et al., 2012). The absorbance at 620 nm was
measured after the addition of 100 µl of BIOMOL reagent. A
standard curve was prepared with pure KH2PO4.
Determination of IC50
The concentration of coumarins required to inhibit both the
polymerization and GTPase activities of MtbFtsZ by 50% (IC50)
was estimated. The coumarins were diluted from 10 to 200 µM
while maintaining the DMSO concentration at 1%. The IC50
for each of the compound was estimated by fitting the data
obtained between concentrations vs. activity using GraphPad
Prisim- version 5. The values represented here is the mean of
three independent experiments. The Km and Vmax were also
calculated in GraphPad Prisim.
Inhibitory Effect of Coumarins on
Mycobacteria
Mycobacterium smegmatis mc2 155 (ATCC 14468) was obtained
from IMTECH, Chandigarh, India. The susceptibility of this
strain toward coumarins was analyzed by Resazurin based
Microtiter alamar blue assay (MABA). The bacteria were
maintained in Middlebrook 7H9 medium (Difco Laboratories,
Detroit, MI, USA), supplemented with OADC (oleic acid/bovine
albumin, dextrose, catalase). Rifampicin and streptomycin were
included as positive control. Coumarins were diluted in either
DMSO or sterile deionized water. The concentration of DMSO
was maintained at 1%. One hundred microliter of 7H9 broth
was dispensed in each well of a sterile flat bottom 96-well plate
and a serial 2-fold dilution of each of these coumarins was
added directly in the wells. The cells of M. smegmatis were
adjusted to late logarithmic phase (A600 > 0.6) and used for the
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assay. Untreated cells served as positive control. The plates were
incubated at 37◦C for 48 h. Alamar blue (10% of the total culture
volume) was added to each well. A change in color from blue to
pink indicated the growth of bacteria and A570 was measured in
Enspire Multimode plate reader (PerkinElmer, NJ, USA). MIC
was determined based on the lowest concentration of coumarin
where no color change was observed. The effect of coumarins
on the bacterial cell length was analyzed by incubating the late
logarithmic M. smegmatis cells with 50 µM of coumarins and
the cells were fixed and mounted to be viewed under a 100 X
objective of Carl-Zeiss Bright field Microscope (Axio Imager 2
for Life Science Research, Germany).
Transmission Electron Microscopy
The polymerization of MtbFtsZ was visualized with TEM. 5 µM
of MtbFtsZ in HEPES buffer, in the presence/absence of 100 µM
of esculetin and 7-dimethyl-4-methyl coumarin was incubated
with GTP (1 mM) for 10min and applied to a carbon-coated
copper grid (300 mesh). They were stained with freshly prepared
2% of sodium tungstate. The grids were blotted dry and the
specimens were viewed with Philips JE, 301 electron microscope
at×50,000 magnification.
Effect of Coumarins on the FtsZ
Localization of M. smegmatis mc2 155
The effect of coumarins on the Z-ring formation ofM. smegmatis
was determined with immunofluoresence microscopy using anti-
FtsZ antibodies (Dziedzic et al., 2010). Late logarithmic phase
cells were grown in the presence and absence of coumarins
for 4 h. The cells were fixed with formaldehyde washed with
phosphate buffer, and immuno-stained with polyclonal anti-FtsZ
rabbit antibody (GeneTeX, USA) overnight at 4◦C. Alexa fluor
(488) goat anti-rabbit secondary antibody (Invitrogen, USA) was
used for visualizing Z-rings. The nuclear material was visualized
by using an anti-mountant containing DAPI. The cells were
visualized in 63 X objective using a Carl-Zeiss fluorescence
Microscope (Axio Imager 2 for Life Science Research, Germany).
The images were visualized and processed using ZEN image
processing software.
RESULTS
Site-Directed Mutagenesis at the GTP
Binding Site
MtbFtsZ was mutated at the G103 residue by site directed
mutagenesis based on literature report that mutations at this
residue alter the GTPase activity of the enzyme (Lu et al., 2001).
In addition to the inactive mutant (G103S) another mutant with
an amino acid alanine (G103A) substitution which may not
completely affect the activity of the protein was also constructed.
The plasmid sequencing was performed to confirm the mutation
at G103 residue.
Docking Score of Coumarins with MtbFtsZ
Based on literature docking of the coumarins was performed at
the putative GTP binding site of MtbFtsZ (PDB ID 2Q1Y) using
the GOLD (Genetic Optimization for Ligand Docking) software
(CCDC). The GOLD score predicts the binding energy values
of the ligands with the protein. Among all the coumarins 7-
Dimethyl-4-methylcoumarin and Daphnetin bind to MtbFtsZ
with the highest docking score (around 42) and they interact with
the G103 residue through hydrogen bonding (Figure 1). The
coumarins such as 4-Hydroxycoumarin and coumarin interact
poorly with a lower GOLD score value (Table 2). The results are
represented as GOLD score fitness which is an original scoring
function in GOLD. It predicts the ligand binding positions by
taking into account the H-bonding energy, van derWaals energy,
metal interaction and ligand torsion strain.
Functional Characterization of Mutants
G103 residue was demonstrated to play a role in MtbFtsZ
(Rajagopalan et al., 2005). Thus, we chose to mutate MtbFtsZ
at this site and generate two mutants of varying activity. The
activity of the mutants was analyzed by GTP hydrolysis assay
and the light scattering assay. The G103S mutant and G103A
retained 10% and 65% of the original (wild type) GTPase activity
respectively (Figure 2A). MtbFtsZ (wild type) yielded 3.64 nM
of inorganic phosphate/min/mg of protein, with a Km of 1.78
± 0.46 nM and a Vmax of 6.28 ± 0.8 nM/min. The Km for
G103S and G103A are 2.6 ± 0.72 nM and 1.8 ± 0.56 nM
respectively while the corresponding Vmax is 4.7 ± 0.78 and 5.4
± 0.86 nM/minute respectively (Figure 2B). The two mutants
retained 8.3% and 40% of the wild type polymerization activity
respectively. The intensity of light scattering is proportional
to the polymerization of the protein. Wild type MtbFtsZ
polymerized the maximum with the highest light scattering
intensity while G103A polymerized to a lesser extent, and the
G103S polymerized the least (Figure 2C).
Effect of Coumarins on the Polymerization
and GTPase Activity of MtbFtsZ Mutants
The IC50 values for the polymerization activity of MtbFtsZ in the
presence of different coumarins with substitutions at 7th position
range from 60 to 125 µM. 7-Dimethyl-4-methylcoumarin
exhibited the maximum inhibition of the polymerization activity
of the protein in a dose dependent manner with an IC50 value of
62.5± 6.7 µM followed by esculetin (65± 4.6 µM). The effect of
coumarins on the GTPase activity is similar with IC50 ranging
from 60 to 135 µM. Daphnetin, esculetin and 7-dimethyl-4-
methylcoumarin inhibited the GTPase activity of the protein the
best (Table 3). Berberine and Totarol, two reported inhibitors
of FtsZ were used as positive controls for both the assays. The
former inhibited 75% ± 2.5 and 82% ± 1.4 of the GTPase and
polymerization activity of the protein respectively, whereas the
corresponding activity of the latter is 68% ± 3.1 and 74% ± 2
respectively (Jaiswal et al., 2007; Stokes et al., 2013).
Table 3 indicates the effect of coumarins on the wild type
and the two mutant proteins. The IC50 was estimated for all
coumarins using both the assays. There is a direct correlation
between the inhibition of GTPase and the polymerization
activities of MtbFtsZ by coumarins. The coumarins lacking a
substitution at the 7th position however did not inhibit the
activity of the enzyme. Similar results were obtained with the
FtsZ from E. coli. The coumarins which did not alter the enzyme
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FIGURE 1 | (A) Interaction of 7-diethyl-4-methylcoumarin with GTP binding site of MtbFtsZ. (B) Indicates the Ligplot representing the interaction of
7-diethyl-4-methylcoumarin with the G103 residue of the GTP binding site. Interaction is through hydrogen bonding. Docking was done using GOLD software.
TABLE 2 | Coumarins docked to the GTP binding site of MtbFtsZ (2Q1Y)
using GOLD software, [a], The GOLD score is given as average of 5
independent runs.
Compound GOLD scorea
Esculetin 37.5
Umbelliferone 35. 5
4-Methylumbelliferone 32.9
4-Hydroxycoumarin 31.8
Coumarin 31.8
7-Diethylamino-4- methylcoumarin 40.1
6-Methylcoumarin 39.7
Daphnetin 42.4
7-Dimethyl-4-methylcoumarin 42.8
activity of wild type protein such as the 4-hydroxycoumarin had
no effect on the activity of the G103A andG103Smutants (IC50>
200 µM) as well. But some of them such as Daphnetin, Esculetin,
and Umbelliferone exhibit variation in IC50 values among the
wild type and mutant proteins.
TEM Analysis of the MtbFtsZ
TEM images confirm that coumarins strongly inhibit the
polymerization and assembly of MtbFtsZ protofilament
(Figure 3). The FtsZ monomers of wild type protein are thick
and appear as a profuse bundle to form a protofilament in
the absence of inhibitor (Figures 3A,B). The presence of
esculetin and 7-dimethyl-4-methylcoumarin did not allow the
formation of network for a protofilament. The filaments are
thin and scattered (Figures 3C,D). Natural products such as
sanguinarine and totarol are reported to induce similar effect
on FtsZ protofilament formation (Jaiswal et al., 2007). G103A
mutant polymerizes to a lesser extent than the wild type to
form a network with thin filaments (Figure 3E). There is no
polymerization observed in the case of G103S mutant and the
monomers are thin (Figure 3F).
The secondary structure of the protein was altered upon
mutation at the G103 residue with serine as indicated previously
(Figure 4A). The troughs at 208 and 220 nm are characteristic of
the alpha helix of the protein, thus a dip at these regions is an
indication of alteration of the secondary structure (Figure 4B).
The characteristic high alpha helix was disturbed upon mutation
and the dip was more apparent by addition of the 7-dimethyl-4-
methyl coumarin.
Coumarins inhibit Growth and Alter the
Morphology of Mycobacterium smegmatis
mc2 155
The effect of coumarins, ellagic acid, Methanol extract (MethExt)
and ethyl acetate fraction (EthAcFr) of pomegranate peels on the
proliferation of Mycobacterium smegmatis mc2 155 was studied
(Table 4). The basic coumarin and 4-hydroxycoumarin exhibit
very poor activity with very high MIC (Table 4). However,
substitutions, especially at the 7th position, have an inhibitory
effect on this bacterium. 7-Dimethyl-4-methyl coumarin is the
most active in this series with aMIC of 36.8µM (Table 4). Recent
reports have indicated that the crude extracts and fractions of
Terminalia species, from South Africa inhibit M. smegmatis
growth (Fyhrquist et al., 2014). The dominant component among
them is ellagic acid in addition to tannins such as punicalagin,
punicalin, chebulanin, chebulagic acid, chebulinic acid, corilagin,
terflavin, terchebulin, and tellimagrandin. All these compounds
were reported to possess anti-microbial activity. Hence in the
current study pure ellagic acid along with pomegranate extract
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FIGURE 2 | Functional characterization of G103S and G103A mutants of MtbFtsZ. (A) GTPase activity of the mutant proteins is expressed as percentage with
respect to wild protein. (B) Represents the kinetics of the mutant and the wild type proteins as analyzed by GTPase hydrolysis assay. (C) Represents the
polymerization activity. Light scattering intensity is represented here which is a measure of the polymerization activity of the protein. The polymerization activity
represented here is the light intensity from 400 to 1,000 s. The graph in (A,B) is representative of three independent experiments.
TABLE 3 | Effect of coumarins on GTPase and polymerization activity of MtbFtsZ.
Compound polymerization activity* GTPase activity**
IC50 ± SD (µM) IC50 ± SD (µM)
Wild type G103S G103A Wild type G103S G103A
Esculetin 84.6 ± 4.7 48.5 ± 2.5 74 ± 5.3 65 ± 4.6 55.5 ± 2.4 69.8 ± 1.7
Umbelliferone 124.2 ± 7.5 52.8 ± 3.8 85 ± 4.72.7 135.2 ± 5.9 52.8 ± 3.5 85 ± 2.3
4-Methylumbelliferone 99.2 ± 3.2 102.4 ± 2.7 112.6 ± 3.4 125.1 ± 4.9 102.4 ± 6.7 112.6 ± 3.9
4-Hydroxycoumarin >200 >200 150 ± 6.4 198 ± 3.5 >200 178.7
Coumarin >200 73 ± 6.6 89 ± 5.4 >200 69.5 ± 5.7 88.3 ± 2.9
7-Diethylamino-4-methyl coumarin 81.54 ± 6.4 65.2 ± 1.8 72.5 ± 3.9 110.3 ± 0.3 78.47 ± 1.8 57.97 ± 3.5
6-Methylcoumarin >200 124.7 ± 6.7 148.4 ± 3.6 >200 136.1 ± 2.9 178.4 ± 2.1
Daphnetin 89.5 ± 6.3 55.2 ± 5.4 78.7 ± 6.1 62.5 ± 5.8 89.5 ± 5.2 94.7 ± 2.9
7-Dimethyl-4-methyl coumarin 74.1 ± 2.8 64.1 ± 2.9 60.9 ± 4.8 64.47 ± 6.7 45.7 ± 1.8 44.2 ± 5.4
The IC50 values were calculated for the polymerization activity and GTPase activity by light scattering assay* and Malachite green assay** respectively as indicated in experimental
section. Data here is represented as mean ± SD of three independent experiments.
(containing ellagic extract) were screened for their ability to
inhibit the growth of M. smegmatis mc2 155. Pure ellagic
acid inhibits M. smegmatis mc2 155 with a MIC of 50 µM.
However, The MethExt and EthAcFr extract from pomegranate
peel inhibit with a MIC of 3.35mg/mL and 0.395mg/mL. These
extracts possess 2 and 17% of ellagic acid, respectively. EthAcFr
has lower MIC value when compared to the reported MIC
(1.5mg/mL) of butanol extract from the bark of the Terminalia
species. The tannins present in the crude extracts probably
augment the inhibitory effect of ellagic acid (Fyhrquist et al.,
2014).
Coumarins also alter the length of M. smegmatis mc2 155.
The average length of the cells without treatment is 4.48 ± 1.25
µm (Figure 5A), However upon treatment with esculetin and
7-dimethyl-4-methylcoumarin the maximum bacterial length
increased 4-fold (17.85± 4.5µmand 15.2± 3.5µm respectively)
(Figures 5B,C). The length of the cells was measured in ImageJ
software. The distribution of cell length is represented in a
histogram where the control cells are maximum in number at the
lower cell length range (2–4 µM) and are absent as the cell length
increases. The cell length distribution of control and coumarin
treated cells indicate that coumarins could induce filamentation
in M. smegmatis mc2 155. The length of Bacillus subtilis 168 was
also reported to increase when treated with coumarins (Duggirala
et al., 2014; Figure 5D).
Localization of MtbFtsZ in Mycobacterium
smegmatis
7-dimethyl-4-methylcoumarin inhibits the growth of M.
smegmatis by altering the length of theMycobacterial cells as well
as disrupting the activity of MtbFtsZ. Hence its effect on FtsZ
assembly in growing cultures of M. smegmatis was analyzed by
immunofluoresence microscopy as indicated in methodology.
FtsZ is stained as a bright green spot in the center of the cells
in the untreated cells (Figure 6A). In the cells treated with this
7-dimethyl-4-methylcoumarin, FtsZ is distributed thought out
the cell as seen as bright green spots (Figure 6B). Thus, the
localization of MtbFtsZ was disrupted when compared with the
control cells.
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FIGURE 3 | Protofilament formation of MtbFtsZwild type and mitant proteins. MtbFtsZ wild type and mutant proteins were polymerized in the presence of 1
mM GTP in HMK buffer in the absence and presence of coumarins. (A,B) Indicates the protofilament formation of wild typeMtbFtsZ (wild type protein where the
monomers are thick and form a profuse network). (C,D) Represent the polymerization of MtbFtsZ in the presence of esculetin and 7-dimethyl-4-methylcoumarin
where the monomers are thin and the network is absent. (E,F) Represent the G103A and G103S proteins. Scale bar for (B,D) 0.2 µM. The arrows point to the
polymerized filaments of protein in case of wildtype and unpolymerized monomers in case of mutants.
DISCUSSION
With the increase in drug resistance there is a need for novel
drugs and those from natural compounds are the need of
hour as they are non-toxic to the host system. Target based
screening of small molecules is an important tool in drug
discovery programmes. Many studies focused on screening
natural compounds, and synthesized small molecules from
combinatorial libraries. FtsZ is one of the essential proteins
during cell division. It serves as a scaffold during the formation of
divisome. There is a growing amount of literature characterizing
FtsZ. It has unique virtues to serve as a target. It is conserved
in all bacterial species; hence an inhibitor could serve as broad
spectrum antibiotic. It shares less sequence homology with
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FIGURE 4 | CD-spectroscopy for the mutant and wild type MtbFtsZ proteins. (A) Indicates the CD spectrum in the absence of coumarin. (B) Indicates the CD
spectrum of wild type and mutant proteins upon treatment with coumarin, 7-dimethyl-4methyl coumarin.
TABLE 4 | Inhibitory effect of coumarins and pomegranate extracts on M.
smegmatis mc2.
Compounds MIC (µM)
Esculetin 48.2 ± 5.7
Umbelliferone 46.2 ± 3.2
4-Methylumbelliferone 42.5 ± 2.4
4-Hydroxylcoumarin 150.2 ± 7.4
Coumarin 213.8 ± 8.7
7-Diethylamino-4-methylcoumarin 70.2 ± 6.2
6-Methylcoumarin 46.8 ± 4.3
Daphnetin 48.2 ± 6.3
7-Dimethyl-4-methylcoumarin 36.8 ± 7.1
Ellagic acid 50 ± 2.4
EthAcFr 0.395 mg/mL
MethEx 3.35mg/mL
Rifampicin (MIC – 3.9 µM) and streptomycin (MIC – 11.17 µM) were used as positive
control. Methanol extract (MethExt) and ethyl acetate fraction (EthAcFr) refers to the ellagic
acid from pomegranate peels as mentioned in Section Materials and Methods.
the eukaryotic homolog tubulin thus it can specifically target
bacterial species. Reduced functional activity of FtsZ results in
inhibition of cell division and cells with filamentous phonotype
are observed (Araújo-Bazán et al., 2016).
Many drug discovery labs are focusing on identification of
anti-TB drugs and many drugs targeting specific enzymes and
pathways are being added to the pipeline. One promising target
for tuberculosis treatment is MtbFtsZ (Mathew et al., 2016).
Though many compounds were reported as FtsZ inhibitors not
many are on their way to clinical trials. Through a systematic
approach we characterize coumarins as anti-mycobacterial
compounds and elucidate theirmechanism of action onMtbFtsZ.
The compounds interacted with G103 residue of the GTP
binding site as demonstrated by Ligplot (Figure 1B). Site directed
mutagenesis was performed at G103 residue to generate variant
proteins with single amino acid substitution namely the G103A
and G103S mutants. The polymerization activity and the GTPase
activity of the MtbFtsZ wild type and the mutant proteins in the
presence of coumarins were analyzed. The extracted coumarins
and the selected coumarins which are reported to have good
biological activity were analyzed for their ability to inhibit the
proliferation ofMycobacterium smegmatismc2 155.
The assembly of FtsZ is GTP driven process. GTP inhibitors
such as C8 analogs employed as FtsZ inhibitors, do not interfere
with tubulin assembly (Marcelo et al., 2013). However, they are
less active on the bacteria as they could not enter them due
to high hydrophobicity of the cell wall. Artola et al. (2015)
synthesized compounds with naphthalene group that replace
GTP as well as inhibit B. subtilis suggesting that they can
penetrate the membrane (Artola et al., 2015). Our docking
analysis indicates that coumarins can bind with good affinity at
the GTP binding site and glycine plays a distinct functional role
on the protein by interacting with the phosphate. Substitution
of glycine with serine during site directed mutagenesis will
destabilize the activity of the enzyme since the latter is a bulky
moiety. Whereas, substitution of glycine with alanine, is reported
to partly retain the activity of enzyme. Moreover, the secondary
structure of the protein remains unaltered upon substituting with
alanine (Ganter and Plückthun, 1990). Site directed mutagenesis
was well employed to study the role of vital residues in FtsZ. For
ex, mutagenesis at single Cys-155 of MtbFtsZ to alanine reduced
the assembly ofMtbFtsZ (Jaiswal and Panda, 2008). Mutations at
the GTP binding site and T7 loop domain of MtbFtsZ altered the
activity of the protein both in vivo and in vitro. G103Smutant was
reported to reduce the GTPase activity of the protein as compared
to the wild type (Rajagopalan et al., 2005). It was reported that
G103S protein which is defective in GTP hydrolysis does not
form Z ring assembly in vivo. Highlighting the importance of
this residue we chose to generate two variant mutants from the
same residue, and we analyzed the activity of the coumarins on
the mutant proteins and wild type.
The enzyme kinetics studies showed that Km of G103A is
closer to that of the wild type indicating that affinity of the protein
to GTP is retained by this mutant, whereas the Km of G103S
is high with a lower Vmax indicating that the affinity of GTP to
this mutant has decreased (decreasing its activity by 40%). And
the activity of G103A mutated protein was decreased only by
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FIGURE 5 | Effect of coumarins on the morphology of M. smegmatis mc2 155—Mid-logarithmic phase cells of Mycobacterium smegmatis were
treated with esculetin and 7-dimethyl-4-methylcoumarin. (A) Control (treated with DMSO), (B,C) represent cells treated with 50 µM of esculetin and
7-dimethyl-4-methylcoumarin respectively. (D) Represents the histograms of distribution of cell length of the control and treated bacteria as measured by ImageJ.
Three different fields were observed for each of the panel and 100 bacterial cells were counted per field.
FIGURE 6 | Immunolocalization of MtbFtsZ in M. smegmatis (A) untreated and (B) treated with 7-dimethyl-4-methyl coumarin. The above figures are the
merged images of the dyes. FtsZ is seen as a green spots all over the cells as seen in the inset and they are not observed in the treated cells. Inset represents the
single bacteria of interest where MtbFtsZ is seen clearly in the control cells (A) Scale 5 µM. Images were obtained in Carl – Zeiss microscope fitted with AxioCam 506.
The filters used were 493–520 nm for alexa fluor and 358–463 nm for DAPI. The arrows indicate the localization of FtsZ in the control cells which is absent in cells
treated with coumarin.
22%. Glycine is known to bind with the phosphate of the GTP
to enable its hydrolysis and substitution with serine reduces the
binding ability of GTP with the protein (Rajagopalan et al., 2005)
whereas substitution with alanine does not affect the binding
ability of GTP to the protein, thus reducing the activity of the
enzyme only partly. It is observed that the kinetics of assembly of
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MtbFtsZ is much slower than that of EcFtsZ, namely, the former
hydrolyses GTP at amuch slower rate than the latter (White et al.,
2000). Polymerization activity is measured by the light scattering
intensity and the peaks of same are achieved for EcFtsZ within
50 s while it took 900 s for the MtbFtsZ (Duggirala et al., 2014).
The assembly kinetics of MtbFtsZ is independent of calcium, and
the turnover of GTP is much slower with it when compared to
that of EcFtsZ (Jaiswal and Panda, 2009). The coumarins lacking
the functional group at the 7th position did not inhibit the activity
of MtbFtsZ and EcFtsZ.
The coumarins had the maximum effect on the wild type
enzyme. The mutation at the G103 residue altered the IC50
values of the coumarins resulting in low drug concentration
requirement for inhibition when compared to wild type. Thus,
the sensitivity of the enzyme to the coumarins was altered upon
mutating at the G103 residue hence emphasizing the importance
of glycine residue on protein activity as well its interaction with
coumarins.
The TEM images are in support of GTPase and polymerization
activities where 7-dimethyl-4-methyl coumarin exhibits a
decrease in IC50 for themutants (Table 3). Plumbagin and totarol
are reported to induce bactericidal effect by increasing the length
of bacteria by 7-fold and 5-fold respectively (Jaiswal et al., 2007;
Bhattacharya et al., 2013). A similar observation is represented
here with esculetin and 7-dimethyl-4-methylcoumarin indicating
a 4-fold increase of M. smegmatis mc2 155 length. These
compounds are reported to primarily target the FtsZ and induce
bacterial cell death. Thus, coumarins also seem to induce cell
elongation and inhibit mycobacterial growth by perturbing
the assembly of MtbFtsZ thereby inducing cell death. FtsZ
inhibitors such as Taxanes, zantrins and viriditoxins also possess
anti-bacterial activity with MIC ranging from 0.25 to 10 µM
toward Bacillus subtilis or pathogenic bacteria such as S. aureus
(Huang et al., 2006; Li and Ma, 2015). The immunofluoresence
studies of FtsZ protein tagged with anti-FtsZ antibodies indicates
that 7-dimethyl-4-methyl coumarin blocked FtsZ assembly and
protofilament formation thus inhibiting cell division as FtsZ
is seen distributed throughout the cells (seen as green spots
in Figure 6B). These microscopic studies collectively show the
inhibitory activity of 7-dimethyl-4-methylcoumarin on MtbFtsZ
protein in support of the IC50 values of these compounds on
MtbFtsZ.
CONCLUSION
Tuberculosis is the most deadly infectious disease and the
emergence of MDR-strains due to irrational usage of drugs has
complicated the scenario. With the urgent need to discover new
drugs with improved efficacy as well as novel specific targets,
FtsZ has received much attention as a promising novel drug
target perhaps due to the low sequence homology with tubulin.
FtsZ in presence of GTP interact with rest of the proteins
viz; FtsA, SulA and ZAP proteins to form the constriction of
membrane. Even though such analogs are absent in MtbFtsZ,
the mutation of the key residue altered the sensitivity of
the coumarins. The current study indicates that coumarins
can be well explored as leads for tuberculosis therapy. They
are also known to be non-toxic to mammalian cells. Ellagic
acid extracts from Pomegranate peels affect the Mycobacterium
more effectively but the tannins could have precipitated the
protein. Chrysophaentins which are non-nucleotide competitive
inhibitors binding to the GTP binding site have been reported.
Two variants of MtbFtsZ (G103S and G103A) were constructed
and the effects of coumarins on the polymerization and GTPase
activity of these were studied to understand the mechanism. The
coumarins perturbed the assembly of MtbFtsZ and the mutation
further destabilzed the secondary structure and polymerization
of protein.
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